Cargando…
Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
BACKGROUND: The urine lipoarabinomannan (LAM) strip-test (Determine®-TB) can rapidly rule-in TB in HIV-infected persons with advanced immunosuppression. However, given high rates of empiric treatment amongst hospitalised patients in high-burden settings (∼50%) it is unclear whether LAM can add any v...
Autores principales: | Peter, Jonathan G., Theron, Grant, Dheda, Keertan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563660/ https://www.ncbi.nlm.nih.gov/pubmed/23390504 http://dx.doi.org/10.1371/journal.pone.0054875 |
Ejemplares similares
-
Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection
por: Gina, Phindile, et al.
Publicado: (2017) -
Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing
por: Peter, Jonny, et al.
Publicado: (2015) -
Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies
por: Lawn, Stephen D, et al.
Publicado: (2013) -
The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis
por: Pandie, Shaheen, et al.
Publicado: (2016) -
What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)